Immunolocalization of β2-glycoprotein I (apolipoprotein H) to human atherosclerotic plaques: Potential implications for lesion progression

Circulation

Volumn 99, Issue 17, 1999, Pages 2227-2230

  George, Jacob ^a   Harats, Dror ^a   Gilburd, Boris ^a   Afek, Arnon ^a   Levy, Yair ^a   Schneiderman, Jacob ^a   Barshack, Iris ^a   Kopolovic, Juri ^a   Shoenfeld, Yehuda ^a  

^a SHEBA MEDICAL CENTER   (Israel)

Author keywords

Antibodies; Atherosclerosis; Glycoproteins; Lipoproteins

Indexed keywords

BETA2 GLYCOPROTEIN 1; CD4 ANTIGEN; CD8 ANTIGEN; CELL ADHESION MOLECULE; PHOSPHOLIPID ANTIBODY; GLYCOPROTEIN; LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN;

ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MACROPHAGE; PRIORITY JOURNAL; ANIMAL; ARTERIOSCLEROSIS; CELL LINE; IMMUNOLOGY; METABOLISM; MOUSE; RABBIT;

ANIMALS; ARTERIOSCLEROSIS; BETA 2-GLYCOPROTEIN I; CELL LINE; GLYCOPROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; LIPOPROTEINS, LDL; MICE; RABBITS;

EID: 0032587108     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.99.17.2227     Document Type: Article

References (13)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809.
2. Libby P, Hansson GK. Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions. Lab Invest. 1991;64:5-11.
3. Witztum JL. The oxidation hypothesis of atherosclerosis. Lancet. 1994; 344:793-795.
4. Wick G, Schett G, Amberger A, Kleindienst R, Xu Q. Is atherosclerosis an immunologically mediated disease? Immunol Today. 1995; 16:27-33.
5. George J, Afek A, Gilburd B, Aron-Maor A, Shaish A, Levkovitz H, Blank M, Harats D, Shoenfeld Y. Induction of early atherosclerosis in LDL receptor deficient mice immunized with β2 glycoprotein I. Circulation. 1998;15:1108-1115.
6. Roubey RAS. Immunology of the antiphospholipid antibody syndrome. Arthritis Rheum. 1996;39:1444-1456.
7. Gharavi AE, Sammaritano LR, Wen J, Elkon KB. Induction of antiphospholipid antibodies by immunization with β2 glycoprotein I (apolipoprotein H). J Clin Invest. 1992;90:1105-1109.
8. Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins. J Clin Invest. 1973;52: 2745-2756.
9. Hasunuma Y, Matsuura E, Makita Z, Katahira T, Nishi S, Koike T. Involvement of β2 glycoprotein I and anticardiolipin antibodies in oxidatively modified low density lipoprotein uptake by macrophages. Clin Exp Immunol. 1997;107:569-574.
10. Stemme S, Faber B, Holm J. T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. Proc Natl Acad Sci USA. 1995;92:3893-3897.
11. Simantov R, LaSala JM, Lo SK, Gharavi AE, Sammaritano LR, Salmon JE, Silverstein RL. Activation of cultured endothelial cells by antiphospholipid antibodies. J Clin Invest. 1995;96:2211-2219.
12. George J, Blank M, Levy Y, Meroni PL, Damianovich M, Tincani A, Shoenfeld Y. Differential effects of anti-β2GPI antibodies on endothelial cells and on the manifestations of experimental antiphospholipid syndrome. Circulation. 1998;97:900-906.
13. Shi W, Chong BH, Chesterman CN. β2-glycoprotein-I is a requirement for anticardiolipin antibodies binding to activated platelets: differences with lupus anticoagulants. Blood. 1993;81:1255-1261.